20260519_INAF_Pengumuman RUPS_32092100_lamp1.pdf

indofarma

Bvotarma Group

ANNOUNCEMENT
ANNUAL GENERAL MEETING OF SHAREHOLDERS
FOR THE FINANCIAL YEAR OF 2025
PT INDOFARMA (PERSERO) TBK

Hereby the Board of Directors of PT Indofarma (Persero) Tbk (“Company”) announce that the
Annual General Meeting of Shareholders for the Financial Year of 2025 of Company (“AGMS”)
will be held on Thursday, June 25, 2026.

In accordance with Financial Services Authority Regulation Number 15/POJK.04/2020
concerning Plans and Implementation of General Meeting of Shareholders of Public
Companies in conjunction with Financial Services Authority Regulation Number
16/POJK.04/2020 concerning the Implementation of Electronic General Meeting of
Shareholders of Public Companies (“OJK Regulation”), the summons for the AGMS will be
made through the eASY.KSEI platform which can be accessed through
htpps://akses.ksei.co.id, the website of the e-GMS provider, the website of the Indonesia
Stock Exchange, and the website of the Company (www.indofarma.id) on June 03, 2026.

Shareholders who are entitled to attend or be represented in the AGMS are Shareholders
whose names are registered in the Shareholders Register of the Company and/or owners of
the Company's share balances in the securities sub-account in the Collective Custody of PT
Kustodian Sentral Efek Indonesia (“KSEI”) at the close of stock trading on the Indonesia Stock
Exchange on June 02, 2026.

In accordance with OJK Regulation Article 16 POJK Number 15/POJK.04/2020, 1 (one)
Shareholder or more representing 1/20 (one twentieth) or more of the total shares issued by
the Company with valid voting rights and Series A Shareholders Dwi Warna has the right to
propose the agenda of the AGMS which must be submitted in writing to the Board of Directors
of the Company no later than 7 (seven) days before the date of the summons for the AGMS,
May 29, 2026, accompanied by the reasons and materials for the proposed AGMS agenda,

and does not conflict with the statutory regulations. if

Jakarta, May 19, 2026
PT Indofarma (Persero) Tbk
Board of Directors